Closing Bell: Nervgen Pharma Corp down on Thursday (NGEN)

In trading today, Nervgen Pharma Corp shares opened at $2.92 and closed at $2.85. Intraday prices ranged from a low of $2.81 to a high of $2.94.

The price dipped -2.40 percent from the previous day's close of $2.92.

Today across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 27,973 shares was traded during the session, with total trades of 64, with an average volume of 46,257 over the last 5 days.

The TSX-V overall saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have soared 66.67%, while they have boosted 5.56% this year.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $204.19 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..